Connect with us

Health

Insys Therapeutics Inc (NASDAQ:INSY) Addresses Arizona Attorney General Grievance

Published

on

Insys Therapeutics Inc

In the first week of September, Insys Therapeutics Inc (NASDAQ:INSY) management reported that they continue to reiterate their initiatives to be part of the offering to the opioid crisis by focusing on helping patients and advancing alternative pain drugs in their research and development. The solutions to this grave national challenge need serious commitment by, and synchronization between, manufacturers, prescribers, patients, governmental authorities and other stakeholders in the healthcare sector.

The details

Encompassed in company’s desire to bring solutions is Insys continuing commitment to take accountability for actions by its former employees and establish high standards of integrity from its current staff. Recent statements made pertaining to the Arizona Attorney General’s probe of their firm lack context and factual accuracy, especially as they link to the roots of the opioid crisis in Arizona. The company had set some of the pertinent facts for consideration.

Insys continue to cooperate with the probe by the Arizona Attorney General office, as it has done and will continue to follow with each governmental authority. The assertions made in the Arizona Attorney General’s complaint link to former staff and physicians that are no longer linked with Insys or its speaker bureau.

By several projections, the national opioid crisis started over a decade and a half earlier. SUBSYS® was introduced in March 2012. In 2016, it formed less than 1,450 prescriptions in Arizona when compared to more than 4.7 million opioid prescriptions in Arizona during the comparable period. In other words, last year, SUBSYS constituted less than 0.03% of all opioid treatments in Arizona.

A doctor is not allowed to prescribe, a pharmacy is not allowed to dispense, and a patient is not allowed to get any Transmucosal Immediate Release Fentanyl product, unless each of them is registered in the FDA required TIRF Risk Evaluation and Mitigation Strategy program. This program strives to restrict the risk of abuse and misuse by limiting prescriptions to appropriate patients, stopping inappropriate conversions between drugs and educating patients, druggists and prescribers about possibility for abuse, overdose and addiction of TIRFs, as well as the marker for these offerings.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Title

Uncategorized4 days ago

Top 15 Essential Oils + Health Benefits

Top 15 Essential Oils + Health Benefits Each and every essential oil contains compounds with unique healing and therapeutic benefits....

Uncategorized4 days ago

Using Hemp Oil in Cooking

Hemp oil has many advocates. The oil from hemp seeds is rich in omega-3 and omega-6 essential fatty acids. This makes...

Uncategorized1 week ago

Best Oil Producers of 2018

Millionaires are being made by the moment in the medical marijuana industry. Venture capital firms, private equity firms, and even...

MyDx Inc MyDx Inc
Health3 weeks ago

MyDx Inc. (OTCMKTS:MYDX) Initiates Clinical Trial of Cannabis Formula for The Treatment of Chronic Low Back Pain

San Diego, CA based MyDx Inc. (OTCMKTS:MYDX) has announced the controlled trial of the cannabis formula for the treatment of...

Business3 weeks ago

Fastfunds Financial Corporation (OTCMKTS:FFFC) Is All Set to Launch Affinity Connextions Program Targeting MMJ Industry

Fastfunds Financial Corporation (OTCMKTS:FFFC) has announced the completion of all necessary formalities to introduce an Affinity Connextions Program through a...

Innovative Industrial Properties Inc Innovative Industrial Properties Inc
Business3 weeks ago

Innovative Industrial Properties, Inc (NYSE:IIPR) Unveils Exercise Of Underwriter’s Option To Purchase Common Stock Shares

Innovative Industrial Properties, Inc (NYSE:IIPR) announced recently that it has obtained the exercise of the underwriter’s option to buy additional...

Business3 weeks ago

Next Generation Management Corporation (OTCMKTS:NGMC) Updates On New Medical Marijuana System in Oregon

Nextgen Holdings, a subsidiary of the Next Generation Management Corporation (OTCMKTS:NGMC) recently updated its stockholders with the ongoing Medical Marijuana...

INDUSTRIAL HEMP3 weeks ago

Weed Inc’s (OTCMKTS:BUDZ) Performance Is Getting Higher

Weed Inc (OTCMKTS:BUDZ) has for a long time been enjoying the momentous highs for the past few months. The company’s...

INDUSTRIAL HEMP3 weeks ago

Namaste Technologies Inc (OTCMKTS:NXTTF) Signs A Share Purchase Agreement With Cannbit Ltd

Namaste Technologies Inc (OTCMKTS:NXTTF) announced recently that it signed a non-binding Letter of Intent (LOI) with Cannabit Limited where the...

INDUSTRIAL HEMP3 weeks ago

MariMed Inc. (OTCMKTS:MRMD) Plans To Expand Its Cannabis Business

MeriMed Inc. (OTCMKTS:MRMD) announced its grand plans to expand business into the emerging cannabis industry. Furthermore, the company intends to...

Advertisement
Advertisement
Advertisement